The Tuberculosis Trials Consortium (TBTC) was named a runner-up for the 2017 Kochon Prize. The Centers for Disease Control and Prevention (CDC) created the TBTC to study the diagnosis, clinical management, and prevention of TB infection and disease. The consortium also promotes research within local TB control programs and provides a forum for international collaborative research. Westat has been providing support for almost 20 years.
“I am proud to be part of a group that has won such recognition,” noted Andrew Vernon, M.D., M.H.S., Chief of the Clinical Research Branch of CDC. “I am grateful for the strong support we have had that has enabled our many partners and us to pursue a shared vision, and that allows us, working together and with others, to contribute to creating a better world for us all.”
The Kochon Prize is awarded annually by Stop TB Partnership to individuals or organizations that have made a significant contribution to combating TB.